National University of Malaysia (UKM)
Department of Medicine
Wan Asyraf Wan Zaidi, the Vice Chairman of Malaysia Stroke Council and World Stroke Organisation future leader programme member, currently works as a clinical lecturer and stroke neurologist at the Department of Medicine, Hospital Canselor Tuanku Muhriz, National University of Malaysia (UKM). Wan Asyraf does research in stroke and neurology. He is interested in stroke prevention (Stroke Riskometer), hyperacute stroke services optimization, stroke imaging, telestroke and education related to vascular neurology. He is currently the national lead investigator for Malaysia, TRIDENT and AVERT DOSE clinical trial. HCTM stroke team is leading the telestroke network establishment during the COVID-19 pandemic. Together with World Stroke Organisation leaders and Malaysia Stroke Council committees , his vision is to improve the stroke awareness among public and healthcare professionals in his country and around the world, and also to provide access for the best evidence-based stroke treatment. Other than he enjoys teaching students and doing research, he loves to spend quality time with his family.

Presenter Of 1 Presentation

Establishing Telestroke Services in LMIC: Experience and Challenges

Session Type
Teaching Course
28.10.2021, Thursday
Session Time
17:45 - 19:15
Lecture Time
18:25 - 18:45


Abstract Body

Hyperacute stroke reperfusion treatment require implementation of a fast team network. Telestroke service allows intra and inter-hospital access to immediate consultation leading to effective and safe stroke treatment. In ASEAN and low-middle income (LMIC) countries the implementation of telestroke service has been slow uptake as it was an optional service prior to the COVID-19 pandemic. The speaker will share the experience and challenges in establishing the telestroke service in LMIC setting which includes lack of staff, cost and billing system, lack of high-speed internet and lack of political will. However due to the recent policy change due to the global pandemic has led to the increasing interest to expand the telestroke treatment in this region. The implementation of regionalised telestroke network will lead to further improvement of care and result in cost effective benefits in this region.